Rhenman & Partners Asset Management AB - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$3,359,000
-44.6%
220,000
-18.5%
0.34%
-54.0%
Q1 2018$6,067,000
-40.5%
270,000
-20.3%
0.75%
-45.8%
Q4 2017$10,204,000
+1119.1%
338,882
+1029.6%
1.38%
+1049.2%
Q2 2017$837,000
-72.9%
30,000
-66.7%
0.12%
-75.5%
Q1 2017$3,094,000
+53.2%
90,000
+28.6%
0.49%
+26.6%
Q4 2016$2,019,000
-99.9%
70,000
+40.0%
0.39%
+53.0%
Q3 2016$1,590,500,000
+97897.5%
50,0000.0%0.25%
-12.2%
Q2 2016$1,623,000
+16.1%
50,0000.0%0.29%
+3.6%
Q1 2016$1,398,000
-67.3%
50,000
-58.3%
0.28%
-57.0%
Q4 2015$4,278,000
-34.0%
120,000
-38.8%
0.65%
-37.4%
Q3 2015$6,482,000
-19.0%
196,000
+2.6%
1.03%
+7.5%
Q2 2015$7,999,000
+43.5%
191,000
+11.7%
0.96%
+2.2%
Q1 2015$5,573,000
+6.4%
171,000
+3.6%
0.94%
-38.1%
Q4 2014$5,239,000
-3.4%
165,000
-24.7%
1.52%
-4.3%
Q3 2014$5,422,000
+4.3%
219,000
-4.8%
1.59%
+3.0%
Q2 2014$5,196,000
+20.7%
230,000
+30.0%
1.54%
+19.3%
Q1 2014$4,304,000
+102.6%
176,883
+108.1%
1.29%
+55.5%
Q4 2013$2,124,00085,0000.83%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders